Hosted on MSN11mon
Drug manufacturer Eli Lilly says two of its diabetes drugs are in short supply - as millions of patients face weeks of chaosPatients will have a harder time getting their Humalog and Insulin Lispro Injections at wholesalers and pharmacies through the beginning of next month, the company said. In the meantime ...
Sanofi’s Admelog (insulin lispro) is approved in type 1 and type 2 diabetes as a follow-on drug to Humalog, a rapid-acting insulin that is Lilly’s top selling drug, bringing in almost $700 ...
Insulin lispro protamine suspension 75% (rDNA origin), insulin lispro 25% (rDNA origin) 100 Units/mL; SC inj; contains zinc, m-cresol. The primary activity of insulin is the regulation of glucose ...
Insulin lispro protamine suspension 50% (rDNA origin), insulin lispro 50% (rDNA origin) 100 Units/mL; SC inj; contains zinc, m-cresol. The primary activity of insulin including Humalog Mix50/50 is ...
and Eli Lilly's Humalog (insulin lispro) – will be priced at no more than $30 per vial and no more than $55 for a box of five pen cartridges – which Civica says is "a significant discount to ...
However, Eli Lilly makes a generic Humalog which costs as low as $8.65. Admelog (Sanofi), a biosimilar insulin lispro which was approved in December 2017, today costs $197. For a patient with no ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results